Mark Groper

Mark Groper is an accomplished executive with significant experience in the biotechnology and consulting industries. As President and CEO of Orion Biotechnology since June 2017, Mark Groper has been at the forefront of developing innovative therapies to address major global health challenges. In addition to this role, Mark Groper serves as a member of the Board of Directors and Chair of the Finance Committee for the Boys & Girls Club since January 2014. Previous roles include serving as a member of the Board of Directors for Novicol Life Sciences, President of Kulman Consulting Group Inc., and Executive Vice-President of Health Solutions at TELUS. Additionally, Mark Groper was President & CEO of DINMAR and worked as a Management Consultant at Accenture early in the career.